![([13C6]Leu15)-pTH (1-34) (human) trifluoroacetate salt](https://densitypharmachem.com/staging/assets/img/products/dummy.png) | CPTD784482 | 1927927-15-8 | Stable isotopes | |
| ([13C6]Leu15)-pTH (1-34) (human) trifluoroacetate salt |
!["([13C6]Leu10)-CRF (human, rat) trifluoroacetate salt"](https://densitypharmachem.com/staging/assets/img/products/dummy.png) | CPTD784964 | 1927927-13-6 | Stable isotopes | |
| "([13C6]Leu10)-CRF (human, rat) trifluoroacetate salt" |
![Fmoc-[ring-D5]Phe-OH](https://densitypharmachem.com/staging/assets/img/products/dummy.png) | CPTD785510 | 225918-67-2 | Stable isotopes | |
| Fmoc-[ring-D5]Phe-OH |
![([D2]Gly4)-Cholecystokinin Octapeptide (sulfated) ammonium salt](https://densitypharmachem.com/staging/assets/img/products/dummy.png) | CPTD786753 | 1926163-74-7 | Stable isotopes | |
| ([D2]Gly4)-Cholecystokinin Octapeptide (sulfated) ammonium salt |
![([ring-D5]Phe3)-Octreotide acetate salt](https://densitypharmachem.com/staging/assets/img/products/dummy.png) | CPTD786754 | 1134880-79-7 | Stable isotopes | |
| ([ring-D5]Phe3)-Octreotide acetate salt |
![([ring-D5]Phe8)-Angiotensin II](https://densitypharmachem.com/staging/assets/img/products/dummy.png) | CPTD786828 | 1926163-73-6 | Stable isotopes | |
| ([ring-D5]Phe8)-Angiotensin II |
!["(Des-Gly10,D-Leu6,[13C6]Leu7,Pro-NHEt9)-LHRH trifluoroacetate salt"](https://densitypharmachem.com/staging/assets/img/products/dummy.png) | CPTD786888 | 1926163-75-8 | Stable isotopes | |
| "(Des-Gly10,D-Leu6,[13C6]Leu7,Pro-NHEt9)-LHRH trifluoroacetate salt" |
![([ring-D5]Phe6)-Somatostatin-14](https://densitypharmachem.com/staging/assets/img/products/dummy.png) | CPTD787498 | 1926163-72-5 | Stable isotopes | |
| ([ring-D5]Phe6)-Somatostatin-14 |
 | CPTD788355 | 63546-27-0 | Stable isotopes | |
| "L-alanine-3,3,3-d3" |
 | CPTD788513 | NA | Stable isotopes | |
| NG-Monomethyl-L-arginine-d7 Hydrochloride (>90%) |